Pharmaceutical M&A, Corporate Strategy & Pipeline Management

Covers pharmaceutical merger and acquisition activity, strategic bolt-on acquisitions for platform capabilities, and intellectual property strategy to navigate patent cliffs. Includes deal structures, R&D optimization, pipeline diversification, and the pursuit of high-growth therapeutic areas and mega-blockbuster assets to ensure long-term revenue stability.